Titre :
  • Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.
Auteur : Pryce, Gareth ; Ahmed, Zubair ; Hankey, Deborah J R ; Jackson, Samuel J ; Croxford, J Ludovic ; Pocock, Jennifer M ; Ledent, Catherine ; Petzold, Axel ; Thompson, Alan J ; Giovannoni, Gavin ; Cuzner, M Louise ; Baker, David
Informations sur la publication : Brain, 126, Pt 10, (page 2191-2202)
Statut de publication : Publié, 2003-10
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Cannabinoids
Excitotoxicity
Experimental allergic encephalomyelitis
Multiple sclerosis
Neuroprotection
Mots-clés MeSH : Animals
Aspartic Acid -- analogs & derivatives
Aspartic Acid -- analysis
Axons -- chemistry
Axons -- pathology
Benzoxazines
Cannabinoids -- therapeutic use
Cyclohexanols -- therapeutic use
Dizocilpine Maleate -- therapeutic use
Encephalomyelitis, Autoimmune, Experimental
Excitatory Amino Acid Agonists -- therapeutic use
Gene Deletion
Humans
Mice
Mice, Transgenic
Monomeric GTP-Binding Proteins -- genetics
Morpholines -- therapeutic use
Multiple Sclerosis -- drug therapy
Multiple Sclerosis -- pathology
N-Methylaspartate -- therapeutic use
Naphthalenes -- therapeutic use
Nerve Degeneration
Nuclear Proteins -- genetics
Receptors, Cannabinoid
Receptors, Drug -- agonists
Receptors, N-Methyl-D-Aspartate -- antagonists & inhibitors
Retina -- drug effects
Retina -- pathology
Saccharomyces cerevisiae Proteins
Spinal Cord -- pathology
Uveitis -- immunology
Note : Journal Article
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0006-8950 
info:doi/10.1093/brain/awg224
info:pii/awg224
info:pmid/12876144